FTRE Overview

Company Profile

Related stocks

PVLA • United States

Palvella Therapeutics, Inc.

138.77 USD

2B USD 1Y +75.5%

GENB • United States

Generate Biomedicines, Inc.

14.34 USD

1.84B USD

SEPN • United States

Septerna, Inc.

38.37 USD

1.79B USD 1Y +64.1%

NTLA • United States

Intellia Therapeutics, Inc.

13.07 USD

1.83B USD 1Y -48.5%

NRIX • United States

Nurix Therapeutics, Inc.

22.35 USD

2.32B USD 1Y +122.5%

MAZE • United States

Maze Therapeutics, Inc.

27.11 USD

1.51B USD 1Y -9.5%

KLRA • United States

Kailera Therapeutics, Inc.

11.61 USD

1.51B USD

COAG • United States

Hemab Therapeutics Holdings, In

31.62 USD

1.48B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

73.6% p.a.

Max Drawdown (3Y)

-89.9%

Sharpe Ratio (3Y)

-0.17

Beta Factor

1.91

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 213%.

High market risk: Beta of 1.91 indicates above-average volatility compared to the broader market.